LSD: a new treatment emerging from the past
Canadian Medical Association Journal August 4, 2015 DOI: 10.1503/cmaj.141358 via OpenAlex
Summary
AI-generated from the abstractPsychedelics lost medical acceptance about 50 years ago, but recent research indicates growing optimism among scientists for their therapeutic revival. More than six decades ago, Albert Hofmann at Sandoz Pharmaceutical Laboratories in Switzerland first synthesized lysergic acid diethylamide (LSD).
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD |
| Keywords | Fell Psychology |
| Citations | 25 |
| Key finding | Psychedelics lost medical acceptance about 50 years ago but recent research suggests growing optimism for their therapeutic return; Albert Hofmann first synthesized LSD over 60 years ago. |
Abstract
Psychedelics fell from medical grace nearly half a century ago, but recent activity suggests that some researchers have "high hopes" for their return.[1][1],[2][2] Over 60 years ago, Albert Hofmann at Sandoz Pharmaceutical Laboratories in Switzerland first synthesized lysergic acid diethylamide